Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

CCR drug updates: sorafenib and sunitinib in renal cell carcinoma.

CCR drug updates: sorafenib and sunitinib in renal cell carcinoma. Clin Cancer Res. 2007 Jul 01; 13(13):3765-70.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.